{"product_id":"sdc-tirzepatide","title":"Tirzepatide 5mg\/10mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Tirzepatide?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eTirzepatide is a synthetic peptide composed of 39 amino acids. The molecule belongs to the incretin analog group and exhibits dual activity on GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This combined receptor profile is precisely what distinguishes it from classic GLP-1 analogs, which primarily act on a single incretin pathway.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eInitially, Tirzepatide was developed in the context of type 2 diabetes mellitus, but clinical trials have also described a significant effect on body weight reduction. In research models, changes in insulin sensitivity, blood sugar control, body composition, and a number of metabolic and cardiovascular parameters have been observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\u003ch2\u003eObservations for Tirzepatide\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eTirzepatide is being investigated for its potential impact on several key metabolic areas:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eBlood sugar control – research and clinical models have observed a reduction in HbA1c and a limitation of glucose spikes.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eWeight reduction – an effect on reducing fat tissue and improving body composition has been described.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eMetabolic health – changes in lipid profile, hepatic steatosis, and other markers associated with metabolic risk have been observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eCardiovascular function – reductions in blood pressure and triglycerides have been described in research settings.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eEnergy homeostasis – an effect on appetite, energy balance, fat oxidation, and metabolic regulation has been observed.\u003c\/p\u003e\n\u003cp class=\"p3\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eTirzepatide has been the subject of extensive clinical trials, in which it has emerged as an incretin analog with a pronounced effect on glycemic control and body weight.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn patients with type 2 diabetes mellitus, the following has been reported:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- HbA1c reduction by up to 2%\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Weight loss of 10-15%\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Improvement in lipid profile and blood pressure\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn people with obesity without diabetes, the following has been observed:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Weight loss of up to 20% over 72 weeks\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Reduction of visceral fat\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Improvement in cardio-metabolic parameters\u003c\/p\u003e\n\u003cp class=\"p3\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eScientific literature describes once-weekly subcutaneous administration within clinical and research protocols.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eStandard doses: 2.5 mg - initial dose with gradual titration up to 5 mg weekly depending on tolerance and therapeutic effect.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eFor 5 mg + 2 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eConcentration = 2.5 mg\/ml → 0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.1 ml = 250μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.2 ml = 500μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.3 ml = 750μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.5 ml = 1.25 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eFor 10 mg + 2 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eConcentration = 5 mg\/ml → 0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eExample values for 10 mg:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.1 ml = 500μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.3 ml = 1.5 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.4 ml = 2 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.5 ml = 2.5 mg\u003c\/p\u003e\n\u003cp class=\"p3\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThe most commonly reported reactions in clinical and research data are related to the gastrointestinal tract, especially during periods of dose escalation.\u003c\/p\u003e\n\u003cp class=\"p3\"\u003ePossible side effects are highly dose-dependent and include:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- nausea, vomiting, diarrhea, constipation\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- decreased appetite\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- abdominal discomfort\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eRarer but more serious risks include:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- pancreatitis\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- gallstone disease with rapid weight reduction\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- hypoglycemia when combined with other antidiabetic agents\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is collected and systematized from various scientific sources and studies. It is for educational purposes only and should not be used for diagnosis, treatment, or prevention of diseases.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"PurePeptide","offers":[{"title":"5mg","offer_id":53386107224407,"sku":null,"price":69.0,"currency_code":"EUR","in_stock":true},{"title":"10mg","offer_id":53386107257175,"sku":null,"price":119.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/Tirzepatide5mg_ff19f292-884d-4c41-be46-84615a825b0a.png?v=1779544821","url":"https:\/\/purepeptide.eu\/products\/sdc-tirzepatide","provider":"PurePeptide","version":"1.0","type":"link"}